Widespread Detection of VEB-1-Type Extended-Spectrum Beta-Lactamases Among Nosocomial Ceftazidime-Resistant Pseudomonas aeruginosa Isolates in Sofia, Bulgaria

References

• Cavallo JD, Fabre R, Leblanc F, Nicolas-Chanonine MH, Thabaut A, Groupe d'Etude de la Resistance de Pseudomonas aeruginosa aux Betalactamines. Antibiotic sus-ceptibility and mechanisms of beta-lactam resistance in 1310 strains of Pseudomonas aeruginosa: a French multicentre study (1996). J Antimicrob Chemother 2000; 46 (1): 133-136.
   Google Scholar
• Bert F, Ould-Hocine Z, Juvin M et al. Evaluation of the Osiris Expert System for identification of beta-lactam pheno-types in isolates of Pseudomonas aeruginosa. J ClinMicrobiol 2003; 41 (8): 3712-3718.
   Google Scholar
• Pechere JC, Kohler T. Patterns and modes of 13-lactam resistance in Pseudomonas aeruginosa. Clin Microbiol Infect 1999; 5 (suppl. 1): S15-S18.
   Google Scholar
• Ziha-Zarifi I, Llanes C, Kohler T, Pechere JC, Plesiat P. In vitro emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux sys-tem MexA-MexB-OprM. Antimicrob Agents Chemother 1999; 43 (2): 287–291.
   PubMed Web of Science ®Google Scholar
• Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001; 47 (3): 247–250.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Guibert M. Extended-spectrum beta-lacta-mases in Pseudomonas aeruginosa. J Antimicrob Chemother 1998; 42 (2): 128–131.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8 (6): 321–331.
   PubMed Web of Science ®Google Scholar
• Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before storm? Clin Micribiol Rev 2005; 18 (2): 306–325.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing: 14th informational supplement. NCCLS document M100-S14. National Committee for Clinical Laboratory Standards, Wayne PA.
   Google Scholar
• Jarlier V, Nicolas M-H, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transfer-able resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pat-terns. Rev Infect Dis 1988; 10 (4): 867–878.
   PubMedGoogle Scholar
• Weldhagen G, Poirel L, Nordmann P. Ambler class A extended-spectrum 13-lactamases in Pseudomonas aeruginosa: novel developments and clinical impacts. Antimicrob Agents Chemother 2003; 47 (8): 2385–2392.
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA, Medeiros AA. A functional classifi-cation scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39 (6): 1211–1233.
   PubMed Web of Science ®Google Scholar
• Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase- producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001; 7 (2): 88–91.
   PubMed Web of Science ®Google Scholar
• Lee S, Park Y-J, Kim M et al. Prevalence of Ambler class A and D 13-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimictob Chemother 2005; 56 (1): 122-127.
   Google Scholar
• Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial suscepti-bility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003; 47 (5): 1681–1688.
   PubMed Web of Science ®Google Scholar
• Petrov M, Hadjieva N, Kantardjiev T, Velinov T, Bachvarova A. Surveillance of antimicrobial resistance in Bulgaria- a synopsis from BuISTAR 2003. Euro Surveill 2005; 10 (6): 79–82.
   PubMedGoogle Scholar
• Gencer S, Ak 0, Benzonana N, Batirel A, Ozer S. Susceptibility patterns and cross resistance of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey. Ann Clin Microbiol Antimicrob 2002; 1: 2.
   Google Scholar
• Kiffer C, Hsiung A, Oplustil C et al. Antimicrobial sus- ceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003. Braz J Infect Dis 2005; 9 (3): 216-224.
   Google Scholar
• Flamm R, Weaver K, Thornsberry C, Jones ME, Karlowsky JA, Sahm DF. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother 2004; 48 (7): 2431–2436.
   PubMed Web of Science ®Google Scholar
• De Champs C, Poirel L, Bonnet R et al. Prospective survey of 13-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob Agents Chemother 2002; 46 (9): 3031-3034.
   Google Scholar
• Bachvarova A, Velinov T, Petrov M, Kantardjiev T, Levterova V, Ivanov I. Widespread detection of VEB-1-type extended-spectrum beta-lactamases among nosocomial Pseudomonas aeruginosa isolates in Bulgaria: a nationwide multicentre study. Clin Microbiol Infect 2005; 11 (suppl. 2): 233.
   Google Scholar
• Girlich D, Naas T, Leelaporn A, Poirel L, Fennewald M, Nordmann P. Nosocomial spread of the integron-located veb-l-like cassette encoding an extended-spectrum 13-lacta-mase in Pseudomonas aeruginosa in Thailand. Clin Infect Dis 2002; 34 (5): 603–611.
   PubMed Web of Science ®Google Scholar
• Poirel L, Rotimi V, Mokaddas E, Karim A, Nordmann P. VEB-1-like extended-spectrum 13-lactamases in Pseudomonas aeruginosa, Kuwait. Emerg Infect Dis 2001; 7 (3): 468–470.
   PubMed Web of Science ®Google Scholar
• Naas T, Poirel L, Karim A, Nordmann P. Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum 13-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiol Lett 1999; 176 (2): 411–419.
   PubMed Web of Science ®Google Scholar
• Vahaboglu H, Ozturk R, Aygun et al. Widespread detection of PER-1-type extended-spectrum 13-lactamases among nosocomial Acinetobacter and Pseudomonas aerugi-nosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997; 41 (10): 2265-2269.
   Google Scholar
• Luzzaro F, Mantengoli, Perilli M et al. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum 13-lacta-mase. J Clin Microbiol 2001; 39 (5): 1865–1870.
   PubMed Web of Science ®Google Scholar
• Claeys G, Verschraegen G, de Baere T, Vaneechoute M. PER-1 P-lactamase-producing Pseudomonas aeruginosa in an intensive care unit. J Antimicrob Chemother 2000; 45 (6): 924–925.
   PubMed Web of Science ®Google Scholar
• Empel J, Filczak K, Mrowka A, Hryniewicz W, Gniadkowski M. The first incidence of PER-1 ESBL-producing Pseudomonas aeruginosa in Poland and identification of a novel OXA beta-lactamase variant. Clin Microbiol Infect 2005;1 (suppl. 2): 235.
   Google Scholar
• Procop GW, Tuohy MJ, Wilson DA, Williams D, Hadziyannis E, Hall GS. Cross-class resistance to non-I3-lactam antimicrobials in extended-spectrum P-lactamase-producing Klebsiella pneumoniae. Am J Clin Pathol 2003; 120 (2): 265–267.
   PubMed Web of Science ®Google Scholar
• Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum 13-lactamase encod-ed by an Escherichia coli integron gene. Antimicrob Agents Chemother 1999; 43 (3): 573–581.
   PubMed Web of Science ®Google Scholar